NewGenIvf Group Limited Class A Ordinary Shares Total Assets
NewGenIvf Group Limited Class A Ordinary Shares total assets. Based on the latest financial reports, NewGenIvf Group Limited Class A Ordinary Shares (NIVF) holds total assets worth $32.72 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of NewGenIvf Group Limited Class A Ordinary for the company's overall valuation and market capitalisation.
Total Assets of NewGenIvf Group Limited Class A Ordinary Shares (2021–2025)
Total assets of NewGenIvf Group Limited Class A Ordinary Shares from 2021 to 2025. This chart illustrates how NewGenIvf Group Limited Class A Ordinary Shares's total assets have evolved over time, based on quarterly financial data. See NIVF stock price and chart for real-time trading data and today's change.
NewGenIvf Group Limited Class A Ordinary Shares - Asset Composition Analysis
NewGenIvf Group Limited Class A Ordinary Shares Total Assets Breakdown (December 2025)
NewGenIvf Group Limited Class A Ordinary Shares total assets breakdown as of December 2025. NewGenIvf Group Limited Class A Ordinary Shares's total assets of $32.72 Million consist of 22.6% current assets and 77.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.3% |
| Accounts Receivable | $1.07 Million | 3.3% |
| Inventory | $335.36K | 1.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $23.05 Million | 70.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how NewGenIvf Group Limited Class A Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore NIVF net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NewGenIvf Group Limited Class A Ordinary Shares's current assets represent 22.6% of total assets in 2025, a decrease from 58.1% in 2021.
- Cash Position: Cash and equivalents constituted 2.3% of total assets in 2025, up from 2.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 70.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 70.4% of total assets.
NewGenIvf Group Limited Class A Ordinary Shares Competitors by Total Assets
Key competitors of NewGenIvf Group Limited Class A Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
|
Sienna Senior Living Inc
TO:SIA
|
Canada | CA$2.35 Billion |
|
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
|
Indonesia | Rp9.98 Trillion |
|
GPT Healthcare Ltd
NSE:GPTHEALTH
|
India | Rs4.65 Billion |
|
The Joint Corp
NASDAQ:JYNT
|
USA | $51.63 Million |
|
Eifelhöhen-Klinik AG
F:EIF
|
Germany | €36.20 Million |
|
Regis Healthcare Ltd
AU:REG
|
Australia | AU$2.11 Billion |
|
Oceania Healthcare Ltd
AU:OCA
|
Australia | AU$3.01 Billion |
NewGenIvf Group Limited Class A Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.12 | 2.19 | 0.65 |
| Quick Ratio | 2.98 | 2.08 | 0.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.02 Million | $1.34 Million | $-41.01K |
NewGenIvf Group Limited Class A Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between NewGenIvf Group Limited Class A Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.08 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | 814.6% |
| Total Assets | $32.72 Million |
| Market Capitalization | $2.15 Million USD |
Valuation Analysis
Below Book Valuation: The market values NewGenIvf Group Limited Class A Ordinary Shares's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: NewGenIvf Group Limited Class A Ordinary Shares's assets grew by 814.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for NewGenIvf Group Limited Class A Ordinary Shares (2021–2025)
The table below shows the annual total assets of NewGenIvf Group Limited Class A Ordinary Shares from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $32.72 Million | +814.62% |
| 2024-12-31 | $3.58 Million | -83.22% |
| 2023-12-31 | $21.32 Million | +633.86% |
| 2022-12-31 | $2.90 Million | +105.62% |
| 2021-12-31 | $1.41 Million | -- |
About NewGenIvf Group Limited Class A Ordinary Shares
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screen… Read more